Skip to main content
. 2021 Jul 21;12:674016. doi: 10.3389/fimmu.2021.674016

Table 1.

Patient and healthy donor characteristics.

AlloTx HD
Participants (n) 46 23
Sex
 Women (n) 15 11
 Men (n) 31 12
Age (yr) 66 (46-85) 46 (22-63)
Time after transplantation (yr) 18 (10-29) /
Cancer (n) 14 /
CsA trough level (ng/ml) 93 (67-129) /

HD, healthy donors; AlloTx, kidney-transplant patients.